AptarGroup, Inc.

• AptarGroup names Virginie Maes president of pharma unit By Investing.com
  Investing.com India · 22 Oct 2026
• AptarGroup names Virginie Maes as president of its pharma unit
  StreetInsider · 22 Oct 2026
• IL-APTARGROUP
  GazetteXtra · 22 Oct 2026
• IL-APTARGROUP
  Black Hills Pioneer · 22 Oct 2026
• AptarGroup, Inc. Announces Appointment of Virginie Maes as President of Aptar Pharma, Effective January 1, 2027
  www.marketscreener.com · 22 Oct 2026
• Wells Fargo Reaffirms Their Buy Rating on AptarGroup (ATR)
  The Globe and Mail · 20 Oct 2026
• UBS starts AptarGroup stock coverage at USD 135.00 target, 8.42 percent above price
  AD HOC NEWS · 17 Oct 2026
• Top AptarGroup (ATR) Competitors 2026
  MarketBeat · 16 Oct 2026
• Is EU Vaccine Device Approval Altering The Investment Case For AptarGroup (ATR)?
  Simply Wall Street · 15 Oct 2026
• Is AptarGroup (ATR) Undervalued As Its Pharma Push Draws Fresh Attention?
  Simply Wall Street · 08 Oct 2026
• AptarGroup (ATR) Edges Up to $120.61 as Shares Hold Mid-Range Support - ETF NAV Deviation
  https://www.siam.in/ · 06 Oct 2026
• AptarGroup's Bottom Line Pressures Are Preventing An Upgrade (NYSE:ATR)
  Seeking Alpha · 27 Sep 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →